US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Squamous Non-Small Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Idiopathic (Essential) Hypertension - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Idiopathic (Essential) Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Venous Leg Ulcers (Crural ulcer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Chronic Bronchitis - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Chronic Bronchitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Uterine Leiomyoma (Uterine Fibroids) - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Uterine Leiomyoma (Uterine Fibroids), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Hypertrophic Scars - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Hypertrophic Scars, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Global Multiple Sclerosis Drugs Market : 2014-2018
8/20/2014 | published by: TechNavio - Infiniti Research Ltd.
... AG, Biogen Idec Inc., Merck Serono SA, Novartis AG and Teva Pharmaceutical Industries Ltd. Other Prominent Vendors in the market are: AB Science, Abbvie, Acorda, Active Biotech, GlaxoSmithKline, Glenmark, Mitsubishi Tanabe, Opexa, Pfizer and Sanofi. ...  |  read more...
USD 3,000
Global Breast Cancer Market Report : 2014 Edition
8/1/2014 | published by: Koncept Analytics
... status or geographic location. The most common risk factors for breast cancer are being female and growing older. In the past few years, the cases of breast cancer have increased tremendously in regions like the ...  |  read more...
USD 800
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market
7/31/2014 | published by: GBI Research
... research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market”. The value of the Non-Small Cell Lung Cancer (NSCLC) market is ...  |  read more...
USD 4,995
Glaucoma - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... Glaucoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Systemic Lupus Erythematosus - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Systemic Lupus Erythematosus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Myelodysplastic Syndrome - Pipeline Review, H2 2014
7/31/2014 | published by: Global Markets Direct
... therapeutic development for Myelodysplastic Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Drug Discovery Technologies - A Global Market Overview
8/28/2014 | published by: Industry Experts
... in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has ...  |  read more...
USD 3,060
Global 3D Bioprinting Market 2014-2018
9/3/2014 | published by: TechNavio - Infiniti Research Ltd.
... A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells. The 3D micro-engineered environments open new ¬channels for drug screening and fundamental studies of wound healing, angiogenesis, ...  |  read more...
USD 2,500
Nanoparticles in Biotechnology, Drug Development and Drug Delivery
8/1/2014 | published by: BCC Research
... $79.8 billion in 2019, with a compound annual growth rate (CAGR) of 22.0% for the period of 2014 to 2019. This report provides: An overview of the global market for nanoparticles in biotechnology, drug development, ...  |  read more...
USD 6,650
Coronary Stenosis Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
... information and data relating to the clinical trials on Coronary Stenosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Coronary Thrombosis Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
... information and data relating to the clinical trials on Coronary Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Coronary Vasospasm Global Clinical Trials Review, H2, 2014
8/20/2014 | published by: GlobalData
... information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...  |  read more...
USD 2,500
Moderate Psoriasis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Moderate Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cachexia - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... Cachexia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Fatigue - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... Fatigue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Deep Vein Thrombosis (DVT), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Lupus Nephritis - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Lupus Nephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Colon Carcinoma - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... therapeutic development for Colon Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
6  7  8  9    11    13  14  15